Table 4 Median estimated disease-specific survival, 5-year disease-specific survival and 10-year disease-specific survival from inital treatment and from the time of diagnosis of metastatic disease
From the initial treatment | From the diagnosis of distant metastases | |||||
|---|---|---|---|---|---|---|
Estimated median length of survival (months) | Estimated 5-year disease-specific survival (%) | Estimated 10-year disease-specific survival (%) | Estimated median length of survival (months) | Estimated 5-year disease-specific survival (%) | Estimated 10-year disease-specific survival (%) | |
All patients | 145 | 81 | 60 | 77 | 54 | 40 |
Pulmonary metastases all patients | 141 | 81 | 60 | 72 | 52 | 31 |
≤3 pulmonary metastases | 100 | 67 | 44 | 32 | 27 | - |
>3 pulmonary metastases | 141 | 77 | 55 | 76 | 70 | 35 |
Without pulmonary metastases | 153 | 74 | 62 | 138 | 55 | 37 |
Bone metastases | 148 | 70 | 68 | 148 | 70 | 50 |
Single organ metastases | 131 | 77 | 52 | 72 | 58 | 37 |
Multiple organ metastases | 145 | 100 | 100 | 93 | 70 | 38 |
Initially metastatic | 141 | 76 | 52 | 141 | 76 | 52 |
Metastatic after disease-free interval | 145 | 81 | 60 | 65 | 44 | 19 |